Reversetaxman: I believe the reason you haven't heard anything from Abbott in so long is because Abbott has no incentive to say anything! I know you are biased in your thinking because you are seeing your investment dwindling, but be logical for one moment. There is no benefit for Abbott stating publicly the progress of recaf development. Complete terms of the licensing agreement aren't public, but we do know that Abbott can return the license with no further obligation at anytime, but they have not (after 18 mos). That is a very positive sign when viewed along the positive statements about the progress from Biocurex, and with the knowledge that Abbott won't make any public statements until they are ready to trigger the milestone payment which will be in the millions.
I like the skepticism surrounding this stock and the pink sheet trading, because it is creating a wonderful buying opportunity. My next purchase price will be @ .43 to bring down my purchasing avg to under a dollar.
